Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Int J Biol Macromol ; 183: 447-456, 2021 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-33932414

RESUMEN

The preparation of ointments from natural compounds is essential for accelerating infected wounds. This study investigated the effects of topical uses of gold nanoparticles (Au)/perlite (Au/Perl) nanocomposites (NCs) by the help of Urtica dioica extract and its chitosan-capped derivative (Chit) on methicillin-resistant Staphylococcus aureus (MRSA)-infected wound healing in a mouse model. Furthermore, Au/Perl/Chit nanocomposite was prepared using protonated chitosan solution. The physicochemical properties of the as-synthesized nanocomposites were also investigated. The effects of Au/Perl/Chit NC were assessed by antibacterial, histopathological parameters as well as molecular evaluations. Then, they were compared with synthetic agent of mupirocin. The results revealed that Au/Perl NC was mesoporous and spherical in a range of 13-15 nm. Topical administration of Au/Perl/Chit ointment accelerated wound healing by reducing bacteria colonization and wound rate enhancing collagen biosynthesis and re-epithelialization, the expressions of IL-10, PI3K, AKT, bFGF, and COL1A genes, which is in agreement with the obtained results for mupirocin. In conclusion, the results strongly demonstrated that administration of ointments prepared from Au/Perl and Au/Perl/Chit nanocomposites stimulates MRSA-infected wound healing by decreasing the length of healing time and regulating PI3K/AKT/bFGF signaling pathway and is a promising candidate in stimulating MRSA-infected wound regeneration.


Asunto(s)
Óxido de Aluminio/farmacología , Antibacterianos/farmacología , Antioxidantes/farmacología , Quitosano/farmacología , Compuestos de Oro/farmacología , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Dióxido de Silicio/farmacología , Piel/efectos de los fármacos , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Urtica dioica/metabolismo , Cicatrización de Heridas/efectos de los fármacos , Óxido de Aluminio/metabolismo , Animales , Antibacterianos/metabolismo , Antioxidantes/metabolismo , Proliferación Celular/efectos de los fármacos , Quitosano/análogos & derivados , Quitosano/metabolismo , Modelos Animales de Enfermedad , Composición de Medicamentos , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fibroblastos/microbiología , Fibroblastos/patología , Compuestos de Oro/metabolismo , Tecnología Química Verde , Masculino , Staphylococcus aureus Resistente a Meticilina/patogenicidad , Ratones , Ratones Endogámicos BALB C , Células 3T3 NIH , Nanopartículas , Nanotecnología , Transducción de Señal , Dióxido de Silicio/metabolismo , Piel/metabolismo , Piel/microbiología , Piel/patología , Infecciones Cutáneas Estafilocócicas/metabolismo , Infecciones Cutáneas Estafilocócicas/microbiología , Infecciones Cutáneas Estafilocócicas/patología , Factores de Tiempo
2.
JCI Insight ; 5(11)2020 06 04.
Artículo en Inglés | MEDLINE | ID: mdl-32493838

RESUMEN

With the effectiveness of antimicrobials declining as antimicrobial resistance continues to threaten public health, we must look to alternative strategies for the treatment of infections. In this study, we investigated an innovative, drug-free, dual-wavelength irradiation approach that combines 2 wavelengths of light, 460 nm and 405 nm, against methicillin-resistant Staphylococcus aureus (MRSA). MRSA was initially irradiated with 460-nm light (90-360 J/cm2) and subsequently irradiated with aliquots of 405-nm light (54-324 J/cm2). For in vivo studies, mouse skin was abraded and infected with approximately 107 CFUs of MRSA and incubated for 3 hours before irradiating with 460 nm (360 J/cm2) and 405 nm (342 J/cm2). Naive mouse skin was also irradiated to investigate apoptosis. We found that staphyloxanthin, the carotenoid pigment in MRSA cells, promoted resistance to the antimicrobial effects of 405-nm light. In addition, we found that the photolytic effect of 460-nm light on staphyloxanthin attenuated resistance of MRSA to 405-nm light killing. Irradiation of 460 nm alone did not elicit any antimicrobial effect on MRSA. In a proof-of-principle mouse skin abrasion infection model, we observed significant killing of MRSA using the dual-wavelength irradiation approach. However, when either wavelength of light was administered alone, no significant decrease in bacterial viability was observed. Moreover, exposure of the dual-wavelength irradiation to naive mouse skin did not result in any visible apoptosis. In conclusion, a dual-wavelength irradiation strategy may offer an innovative, effective, and safe approach for the treatment of skin infections caused by MRSA.


Asunto(s)
Staphylococcus aureus Resistente a Meticilina/crecimiento & desarrollo , Fototerapia , Infecciones Cutáneas Estafilocócicas , Animales , Modelos Animales de Enfermedad , Infecciones Cutáneas Estafilocócicas/metabolismo , Infecciones Cutáneas Estafilocócicas/patología , Infecciones Cutáneas Estafilocócicas/terapia
3.
Biomed Pharmacother ; 111: 705-713, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30611995

RESUMEN

Garcinia mangostana (mangosteen) pericarp has antibacterial effects; however, information regarding its anti-inflammatory activity in vivo is limited. The anti-inflammatory effect of G. mangostana pericarp extract against methicillin-resistant Staphylococcus aureus (MRSA)-induced superficial skin infection was investigated in mice using a tape stripping model. G. mangostana pericarp ethanolic extract (GME) and its constituent, α-mangostin, were topically administered to mice with MRSA-induced superficial skin infection. MRSA-infected wounds treated with GME were completely healed on the 10th day of the study and the number of MRSA-colonies decreased from the first day of the study, whereas α-mangostin-treated wounds never completely healed with higher numbers of MRSA colonies. The epidermis of GME-treated wounds had nearly completely regenerated, with no inflammatory cell infiltration. In contrast, α-mangostin-treated wounds exhibited neutrophil infiltration and accumulation of mast cells. MRSA-infected wounds without treatment showed high expression of TNF-α, IL-6, IL-1ß, and TLR-2 genes. In contrast, GME decreased mRNA levels, restoring expression of those genes to normal levels. Notably, α-mangostin did not down-regulate the expression of pro-inflammatory cytokines to the same extent as GME. Hence, GME is a promising alternative MRSA treatment because of its antibacterial, anti-inflammatory, and wound healing effects.


Asunto(s)
Antiinflamatorios/uso terapéutico , Garcinia mangostana , Mediadores de Inflamación/antagonistas & inhibidores , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Extractos Vegetales/uso terapéutico , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Animales , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/farmacología , Mediadores de Inflamación/metabolismo , Masculino , Staphylococcus aureus Resistente a Meticilina/fisiología , Ratones , Ratones Endogámicos ICR , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/metabolismo , Infecciones Estafilocócicas/patología , Infecciones Cutáneas Estafilocócicas/metabolismo , Infecciones Cutáneas Estafilocócicas/patología , Resultado del Tratamiento
4.
ACS Appl Mater Interfaces ; 11(1): 300-310, 2019 Jan 09.
Artículo en Inglés | MEDLINE | ID: mdl-30520301

RESUMEN

Abuse of antibiotics and their residues in the environment results in the emergence and prevalence of drug-resistant bacteria and leads to serious health problems. Herein, a photon-controlled antibacterial platform that can efficiently kill drug-resistant bacteria and avoid the generation of new bacterial resistance was designed by encapsulating black phosphorus quantum dots (BPQDs) and pharmaceuticals inside a thermal-sensitive liposome. The antibacterial platform can release pharmaceuticals in a spatial-, temporal-, and dosage-controlled fashion because the BPQDs can delicately generate heat under near-infrared light stimulation to disrupt the liposome. This user-defined delivery of drug can greatly reduce the antibiotic dosage, thus avoiding the indiscriminate use of antibiotics and preventing the generation of superbugs. Moreover, by coupling the photothermal effect with antibiotics, this antibacterial platform achieved a synergistic photothermal-/pharmaco-therapy with significantly improved antibacterial efficiency toward drug-resistant bacteria. The antibacterial platform was further employed to treat antibiotic-resistant bacteria-caused skin abscess and it displayed excellent antibacterial activity in vivo, promising its potential clinical applications. Additionally, the antibacterial mechanism was further investigated. The developed photon-controlled antibacterial platform can open new possibilities for avoiding bacterial resistance and efficiently killing antibiotic-resistant bacteria, making it valuable in fields ranging from antiinfective therapy to precision medicine.


Asunto(s)
Antibacterianos , Hipertermia Inducida , Rayos Infrarrojos , Staphylococcus aureus Resistente a Meticilina/crecimiento & desarrollo , Fototerapia , Puntos Cuánticos , Infecciones Cutáneas Estafilocócicas , Animales , Antibacterianos/química , Antibacterianos/farmacocinética , Antibacterianos/farmacología , Liposomas , Ratones , Puntos Cuánticos/química , Puntos Cuánticos/uso terapéutico , Infecciones Cutáneas Estafilocócicas/metabolismo , Infecciones Cutáneas Estafilocócicas/patología , Infecciones Cutáneas Estafilocócicas/terapia
5.
Immun Inflamm Dis ; 5(3): 265-279, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28480538

RESUMEN

INTRODUCTION: Flavonoids are converted to inactive metabolites like glucuronides in the gut, and circulate mainly as glucuronides in blood stream, resulting in low concentrations of active aglycones in plasma. It is therefore unclear how oral flavonoids exert their effects in tissues. We recently reported the plasma pharmacokinetics of some flavonoids and suggested the possibility that the absorbed flavonoids modified macrophage functions leading to enhance bacterial clearance. We aimed to confirm their pharmacological profiles focusing on tissue macrophages. METHODS: Pseudoinfection was induced by intradermal injection of FITC-conjugated and killed Staphylococcus aureus into the ears of mice treated with or without genistein 7-O-glucuronide (GEN7G, 1 mg/kg, i.v.). FACS analysis was performed on single cell suspensions dispersed enzymatically from the skin lesions at 6 h post pseudoinfection to evaluate phagocytic activities of monocytes/macrophages (CD11b+ Ly6G- ) and neutrophils (CD11b+ Ly6G+ ). Phagocytosis of the FITC-conjugated bacteria by four glucuronides including GEN7G was evaluated in cultures of mouse macrophages. RESULTS: After GEN7G injection, genistein was identified in the inflamed ears as well as GEN7G, and the phagocytic activity of CD11b+ Ly6G- cells was increased. GEN7G was converted to genistein by incubation with macrophage-related ß-glucuronidase. Macrophage culture assays revealed that GEN7G increased phagocytosis, and the action was dampened by a ß-glucuronidase inhibitor. Binding of aglycones to estrogen receptors (ERs), putative receptors of flavonoid aglycones, correlated to biological activities, and glucuronidation reduced the binding to ERs. An ER antagonist suppressed the increase of macrophage function by GEN7G, whereas estradiol enhanced phagocytosis as well. CONCLUSIONS: This study suggests a molecular mechanism by which oral flavonoids are carried as glucuronides and activated to aglycones by ß-glucuronidase in tissue macrophages, and contributes to the pharmacological study of glucuronides.


Asunto(s)
Flavonoides/metabolismo , Glucuronidasa/metabolismo , Glucurónidos/metabolismo , Macrófagos/metabolismo , Fitoestrógenos/metabolismo , Infecciones Cutáneas Estafilocócicas/metabolismo , Staphylococcus aureus , Animales , Macrófagos/patología , Ratones , Ratones Endogámicos ICR , Infecciones Cutáneas Estafilocócicas/patología
6.
J Infect Chemother ; 19(3): 447-55, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23085743

RESUMEN

Daptomycin is a lipopeptide antibiotic active against gram-positive organisms and recently approved for marketing in Japan. This study investigates the efficacy and safety of daptomycin in Japanese patients with skin and soft tissue infections (SSTIs) caused by methicillin-resistant Staphylococcus aureus (MRSA) for regulatory filing in Japan. Overall, 111 Japanese patients with SSTI were randomized in this open-label, randomized, active-comparator controlled, parallel-group, multicenter, phase III study. Patients received intravenous daptomycin 4 mg/kg once daily or vancomycin 1 g twice daily for 7-14 days. Efficacy was determined by a blinded Efficacy Adjudication Committee. Among patients with SSTIs caused by MRSA, 81.8 % (95 % CI, 69.1-90.9) of daptomycin recipients and 84.2 % (95 % CI, 60.4-96.6) of vancomycin recipients achieved a successful clinical response at the test-of-cure (TOC) visit. The microbiological success rate against MRSA at the TOC visit was 56.4 % (95 % CI, 42.3-69.7) with daptomycin and 47.4 % (95 % CI, 24.4-71.1) with vancomycin. Daptomycin was generally well tolerated; most adverse events were of mild to moderate severity. The measurement of daptomycin concentration in plasma revealed that patients with mild or moderate impaired renal function showed similar pharmacokinetics profiles to patients with normal renal function. Clinical and microbiological responses, stratified by baseline MRSA susceptibility, suggested that patients infected with MRSA of higher daptomycin MIC showed a trend of lower clinical success with a P value of 0.052 by Cochran-Armitage test. Daptomycin was clinically and microbiologically effective for the treatment of MRSA-associated SSTIs in Japanese patients.


Asunto(s)
Antibacterianos/efectos adversos , Antibacterianos/uso terapéutico , Daptomicina/efectos adversos , Daptomicina/uso terapéutico , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacocinética , Creatinina/sangre , Creatinina/metabolismo , Daptomicina/farmacocinética , Femenino , Humanos , Pruebas de Función Renal , Masculino , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Infecciones de los Tejidos Blandos/metabolismo , Infecciones de los Tejidos Blandos/microbiología , Infecciones Cutáneas Estafilocócicas/metabolismo , Infecciones Cutáneas Estafilocócicas/microbiología , Vancomicina/uso terapéutico
7.
Zhongguo Zhong Yao Za Zhi ; 37(6): 735-8, 2012 Mar.
Artículo en Chino | MEDLINE | ID: mdl-22715711

RESUMEN

OBJECTIVE: To study the effect of repeated administration of Zhuhong ointment on renal antioxidant capability of ulcerous skin in rats, in order to further discuss the mechanism of mercury contained in Zhuhong ointment on the antioxidant capability of kidney in skin ulcer rats. METHOD: Eighty SD rats were randomly divided into eight groups: Zhuhong ointment A, B, C, D, E (1.219, 0.609, 0.305, 0.152, 0.76 g x kg(-1)) groups, the vaseline group, the ulcer model group and the impairment control group. The levels of NAG and RBP of toxicity for early kidney tubular injury and T-AOC, SOD, GSH-PX and GSH in kidney were determined after consecutive administration for 14 days. RESULT: Compared with ulcer model group, the levels of RBP in groups A, B, C and D increased, while the levels of NAG increased only in the group A. The level of T-AOC increased in groups A, B and C. The level of T-SOD increased in the group E, while it dropped down greatly in the group A. The level of GSH-PX increased in groups A, B and C. The content of GSH increased in every dose groups. CONCLUSION: Antioxidant capacity in rats can be increased in a reasonable dose of Zhuhong ointment, but some antioxidant activity can be notably inhibited by with the increase of dose.


Asunto(s)
Antioxidantes/metabolismo , Medicamentos Herbarios Chinos/farmacología , Túbulos Renales/efectos de los fármacos , Mercurio/metabolismo , Úlcera Cutánea/metabolismo , Infecciones Cutáneas Estafilocócicas/metabolismo , Acetilglucosaminidasa/efectos de los fármacos , Acetilglucosaminidasa/orina , Animales , Antioxidantes/análisis , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/toxicidad , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Túbulos Renales/lesiones , Túbulos Renales/metabolismo , Masculino , Pomadas , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Proteínas de Unión al Retinol/efectos de los fármacos , Proteínas de Unión al Retinol/orina , Úlcera Cutánea/microbiología , Organismos Libres de Patógenos Específicos , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Factores de Tiempo
8.
Exp Dermatol ; 19(7): 628-32, 2010 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-20100198

RESUMEN

Skin wounds usually heal without major infections, although the loss of the mechanical epithelial barrier exposes the tissue to various bacteria. One reason may be the expression of antimicrobial peptides (AMP) of which some [human beta-defensins (hBD) and LL-37] were recently shown to support additionally certain steps of wound healing. There are no studies which have compared expression patterns of different classes of AMP in chronic wounds. The aim of our study was therefore to analyse the expression profile of hBD-2, hBD-3, LL-37, psoriasin and RNase 7 by immunohistochemistry from defined wound margins of chronic venous ulcers. We detected a strong induction of psoriasin and hBD-2 in chronic wounds in comparison with healthy skin. Except for stratum corneum, no expression of RNase 7 and LL-37 was detected in the epidermis while expression of hBD-3 was heterogeneous. Bacterial swabs identified Staphylococcus aureus and additional bacterial populations, but no association between colonization and AMP expression was found. The differential expression of AMP is noteworthy considering the high bacterial load of chronic ulcers. Clinically, supplementation of AMP with the capability to enhance wound healing besides restricting bacterial overgrowth could present a physiological support for treatment of disturbed wound healing.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/biosíntesis , Heridas y Lesiones/metabolismo , Anciano , Péptidos Catiónicos Antimicrobianos/genética , Perfilación de la Expresión Génica , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Ribonucleasas/biosíntesis , Proteína A7 de Unión a Calcio de la Familia S100 , Proteínas S100/biosíntesis , Infecciones Cutáneas Estafilocócicas/metabolismo , Infecciones Cutáneas Estafilocócicas/microbiología , Úlcera Varicosa/metabolismo , Úlcera Varicosa/microbiología , Heridas y Lesiones/genética , Heridas y Lesiones/microbiología , beta-Defensinas/biosíntesis , Catelicidinas
9.
Artículo en Ruso | MEDLINE | ID: mdl-1441815

RESUMEN

The influence of dimephosphone at concentrations of 0.001 M-0.75 M on the chemiluminescence of tissues at the focus of purulent infection in the ear of a guinea pig, on the survival rate of the experimental animals injected with the lethal dose of Staphylococcus aureus, as well as on the spontaneous and stimulated chemiluminescence of blood neutrophils in patients with wound infection, was studied. The study showed that different concentrations of dimephosphone oppositely influenced the intensity of the chemiluminescence of neutrophil suspensions and tissues at the focus of infection: low concentrations were found to produce stimulating action and high concentrations, suppressive action. At the highest concentration used in this study (0.75 M) dimephosphone prevented the death of the animals receiving lethal doses of S. aureus.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Infección Focal/tratamiento farmacológico , Mediciones Luminiscentes , Neutrófilos/efectos de los fármacos , Compuestos Organofosforados/uso terapéutico , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Animales , Células Cultivadas/efectos de los fármacos , Células Cultivadas/metabolismo , Distribución de Chi-Cuadrado , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Infección Focal/metabolismo , Infección Focal/mortalidad , Cobayas , Humanos , Masculino , Neutrófilos/metabolismo , Infecciones Cutáneas Estafilocócicas/metabolismo , Infecciones Cutáneas Estafilocócicas/mortalidad , Infección de Heridas/tratamiento farmacológico , Infección de Heridas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA